Belgium· BE-AMP-SAM207487-00
Mifegyne 200 mg
A mifepristone product containing mifepristone, registered in Belgium by Exelgyn. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Mifepristone is registered in 14 of 19 countries.
Countries holding a registration under ATC G03XB01 (mifepristone), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Mifepristone · ATC G03XB01
14 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of mifepristone costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Mifepristone · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$53.60
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Mifepristone
- Manufacturer
- Exelgyn
- Country
- Belgium (BE)
- ATC code
- G03XB01
- ATC class
- Mifepristone
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0793000
- be_apb1574490
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
378 interactions on record for mifepristone.
Graded by severity as the source publishes them — 209 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Mifepristone · interactions on record
378 records
- 209 severe
- 161 moderate
- 8 minor
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Mifepristone in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsMifegyne 200 mg, tablettenEuro Registratie Collectief B.V.
- CzechiaMIFEGYNEExelgyn, Paris
- United StatesKorlymCorcept Therapeutics Incorporated
- FinlandMifegyneParanova Oy
- United KingdomMifegyne 200mg tabletsNordic Pharma Ltd
- SpainMIFEGYNE 200 mg COMPRIMIDOSExelgyn
- FranceMIFEGYNE 200 mg, compriméEXELGYN
- IrelandMifegyne 200 mg tabletsEXELGYN
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mifegyne
- Bulgaria · Мифегин
- Cyprus · Mifegyne
- Czechia · Mifegyne
- Germany · Mifegyne
- Denmark · Mifegyne
- Estonia · Mifegyne
- Spain · Mifegyne
- Finland · Mifegyne
- France · Mifegyne, Miffee
- United Kingdom (Northern Ireland) · Mifegyne, Mifepristone Linepharma
- Greece · Mifegyne
- Croatia · Mifegyne
- Ireland · Mifegyne
- Iceland · Mifegyne
- Italy · Mifegyne
- Lithuania · Mifegyne
- Luxembourg · Mifegyne
- Latvia · Mifegyne
- Netherlands · Mifegyne
- Norway · Mifegyne
- Portugal · Mifegyne
- Romania · Mifegyne
- Sweden · Mifegyne, Mifepristone Nordic
- Slovenia · Mifegyne
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/57e31e18-ccdf-4f50-bdc4-5b4bc54aba85 GET /v1/drugs/57e31e18-ccdf-4f50-bdc4-5b4bc54aba85?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Mifegyne 200 mg",
"name_fr": "Mifegyne 200 mg",
"name_nl": "Mifegyne 200 mg",
"amp_code": "SAM207487-00",
"strengths": [
"200.0000"
],
"pack_count": 4,
"substances": [
"Mifepristone"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Mifepristone",
"authorisation_numbers": [
"BE207487"
]
}See everything about mifepristone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.